The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation☆
Abstract
OBJECTIVE: Reactive oxygen species (ROS) produced by NAD(P)H oxidases (Nox) play a significant role in the pathophysiology of cardiovascular diseases. Expression and activity of NAD(P)H oxidases are regulated by growth factors such as angiotensin II and platelet-derived growth factor (PDGF). We characterized the effects of the novel Nox inhibitor VAS2870 on PDGF-dependent ROS liberation and cellular events in vascular smooth muscle cells (VSMC). METHODS AND RESULTS: PDGF-BB increased NAD(P)H oxidase activity (lucigenin-enhanced chemiluminescence) and intracellular ROS levels (detected by confocal laserscanning microscopy using 2,7-DCF) to 229+/-9% and 362+/-54% at 1 and 2 h, respectively. Preincubation with VAS2870 (10 and 20 microM) completely abolished PDGF-mediated NAD(P)H oxidase activation and ROS production. Since ROS are involved in various growth factor-induced cellular functions, the influence of VAS2870 on PDGF-induced DNA synthesis and chemotaxis was determined. PDGF promoted a 4.2+/-0.2-fold increase of VSMC migration (modified Boyden chamber, p<0.01) and increased DNA synthesis by maximally 3.2+/-0.4-fold (BrdU incorporation, p<0.01) in a concentration-dependent manner. Preincubation with VAS2870 (0.1-20 microM) did not affect PDGF-induced cell cycle progression. However, it abolished PDGF-dependent chemotaxis of VSMC in a concentration-dependent manner (100% inhibition at 10 microM). These findings were related to PDGF-dependent signaling events. Western blot analyses using phospho-specific antibodies revealed that the downstream signaling molecules Akt, Erk, and Src were activated by PDGF. However, VAS2870 blocked PDGF-dependent activation of Src, but not of Akt and Erk, in a concentration-dependent manner. CONCLUSIONS: VAS2870 effectively suppresses growth factor-mediated ROS liberation in VSMC. Furthermore, it completely inhibits PDGF-dependent VSMC migration, whereas it does not affect DNA synthesis. These divergent effects reflect the critical role of Src activity, which-in contrast to Akt and Erk-appears to be redox-sensitive and is absolutely required for PDGF-induced chemotaxis, but not cell cycle progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This scheme has been found to apply to virtually all the heme protein–mediated nitrite reduction reactions studied to date, including Hb (248, 447), Mb (247, 862), neuroglobin (Ngb) (932, 945), Cygb (182, 571, 780), cystathionine β-synthase (CBS) (149, 350), globin X (184), plant and cyanobacterial Hb (phytohemoglobins) (905, 946), flavohemoglobin (340), heme-albumin (43), cytochrome c (41), prot”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [932]
In the citing paper
“It was recently demonstrated that, as observed with other globins, deoxygenated Ngb can also reduce nitrite to NO (932, 945).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [932]
In the citing paper
“However, although initial experiments suggested VAS2870 to be Nox2-specific, it is definitely not [341,393,403,404].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [404]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
Requirement for Generation of H 2 O 2 for Platelet-Derived Growth Factor Signal Transduction
Sundaresan, M., Yu, Z.-X., Ferrans, V. J., Irani, K., & Finkel, T. (1995) · Science · doi:10.1126/science.270.5234.296 · Cited by 2,520
The smooth muscle cell in culture
Chamley-Campbell, J. H., CAMPBELL, G. R., & Ross, R. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.1.1 · Cited by 1,560
Cell transformation by the superoxide-generating oxidase Mox1
Suh, Y.-A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., & Lambeth, J. D. (1999) · Nature · doi:10.1038/43459 · Cited by 1,480
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Lassegue, B. P., & Clempus, R. E. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2002 · Cited by 1,026
Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis
Sorescu, D., Weiss, D., Lassègue, B., Clempus, R. E., Szöcs, K., Sorescu, G. P., Valppu, L., Quinn, M. T., Lambeth, J. D., Vega, J. D., et al. (2002) · Circulation · doi:10.1161/01.cir.0000012917.74432.66 · Cited by 847
Identification of Renox, an NAD(P)H oxidase in kidney
Geiszt, M., Kopp, J. B., Várnai, P., & Leto, T. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130135897 · Cited by 840
Lassègue, B., Sorescu, D., Szöcs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., & Griendling, K. K. (2001) · Circulation Research · doi:10.1161/hh0901.090299 · Cited by 839
Homologs of gp91 phox : cloning and tissue expression of Nox3, Nox4, and Nox5
Cheng, G., Cao, Z., Xu, X., Meir, E. G. V., & Lambeth, J. D. (2001) · Gene · doi:10.1016/s0378-1119(01)00449-8 · Cited by 820
The superoxide-generating NADPH oxidase: structural aspects and activation mechanism
Vignais, P. V. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8520-9 · Cited by 799
Research works printed but not linked: 1
- Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal trans- duction. Science 1995;270:296 -9.
Cited by
Sorted by citations
Items 101–200 of 263
van der Post, S., Birchenough, G. M. H., & Held, J. M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108949 · Cited by 70
NADPH Oxidase as a Therapeutic Target for Oxalate Induced Injury in Kidneys
Joshi, S. K., Peck, A. B., & Khan, S. R. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/462361 · Cited by 70
NADPH oxidases: Pathophysiology and therapeutic potential in age-associated pulmonary fibrosis
Kato, K., & Hecker, L. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101541 · Cited by 67
Carbone, F., Teixeira, P. C., Braunersreuther, V., Mach, F., Vuilleumier, N., & Montecucco, F. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5778 · Cited by 68
Menden, H. L., Tate, E. R., Hogg, N., & Sampath, V. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00261.2012 · Cited by 65
VAS2870 is a pan-NADPH oxidase inhibitor
Wingler, K., Altenhöfer, S., Kleikers, P. W. M., Radermacher, K. A., Kleinschnitz, C., & Schmidt, H. H. H. W. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1107-1 · Cited by 70
Self-citationImatinib mesylate for the treatment of pulmonary arterial hypertension
ten Freyhaus, H., Dumitrescu, D., Berghausen, E. M., Vantler, M., Caglayan, E., & Rosenkranz, S. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.632408 · Cited by 63
Self-citationEarly bioelectric activities mediate redox-modulated regeneration
Ferreira, F., Luxardi, G., Reid, B., & Zhao, M. (2016) · Development · doi:10.1242/dev.142034 · Cited by 63
NOX Inhibitors - A Promising Avenue for Ischemic Stroke
Kim, J. Y., Park, J., Lee, J. E., & Yenari, M. A. (2017) · Experimental Neurobiology · doi:10.5607/en.2017.26.4.195 · Cited by 62
Reactive oxygen species as potential antiviral targets
Sander, W. J., Fourie, C., Sabiu, S., O’Neill, F. H., Pohl, C. H., & O’Neill, H. G. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2240 · Cited by 62
NADPH Oxidase Inhibition: Preclinical and Clinical Studies in Diabetic Complications
Urner, S., Ho, F., Jha, J. C., Ziegler, D., & Jandeleit-Dahm, K. A. M. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8047 · Cited by 66
Kuzmanov, A., Hopfer, U., Marti, P., Meyer‐Schaller, N., Yilmaz, M., & Christofori, G. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.12.009 · Cited by 64
Sullivan, C., Soos, B.-L., Millard, P. J., Kim, C. H., & King, B. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.636623 · Cited by 57
ten Freyhaus, H., Berghausen, E. M., Janssen, W., Leuchs, M., Zierden, M., Murmann, K., Klinke, A., Vantler, M., Caglayan, E., Kramer, T., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304864 · Cited by 60
Self-citationNocella, C., D’Amico, A., Cammisotto, V., Bartimoccia, S., Castellani, V., Loffredo, L., Marini, L., Ferrara, G., Testa, M., Motta, G., et al. (2023) · Antioxidants · doi:10.3390/antiox12020429 · Cited by 63
Neuronal NAD(P)H Oxidases Contribute to ROS Production and Mediate RGC Death after Ischemia
Dvoriantchikova, G., Grant, J., Santos, A. R. C., Hernandez, E., & Ivanov, D. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9526 · Cited by 59
Fujii, T., Shimizu, T., Yamamoto, S., Funayama, K., Fujita, K., Tabuchi, Y., Ikari, A., Takeshima, H., & 酒井, 秀. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.014 · Cited by 58
Kundi, R., Hollenbeck, S. T., Yamanouchi, D., Herman, B. C., Edlin, R. S., Ryer, E. J., Wang, C., Tsai, S. X., Liu, B., & Kent, K. C. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp220 · Cited by 58
Hosseini, E., Ghasemzadeh, M., Atashibarg, M., & Haghshenas, M. (2019) · Transfusion · doi:10.1111/trf.15114 · Cited by 58
Feng, Y.-Y., Tang, M., Suzuki, M., Gunasekara, C. P., Anbe, Y., Hiraoka, Y., Liu, J., Grasberger, H., Ohkita, M., Matsumura, Y., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800443 · Cited by 61
Gene Transfer of Redox Factor-1 Inhibits Neointimal Formation
Lee, H. M., Jeon, B. H., Won, K., Lee, C., Park, T.-K., Choi, W. S., Bae, Y. M., Kim, H. S., Lee, S. K., Park, S. H., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.178699 · Cited by 57
Translating the oxidative stress hypothesis into the clinic: NOX versus NOS
Armitage, M. E., Wingler, K., Schmidt, H. H. H. W., & La, M. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0544-2 · Cited by 56
Self-citationBimodal role of NADPH oxidases in the regulation of biglycan-triggered IL-1β synthesis
Hsieh, L. T.-H., Frey, H., Nastase, M.-V., Tredup, C., Hoffmann, A., Poluzzi, C., Zeng-Brouwers, J., Manon‐Jensen, T., Schröder, K., Brandes, R. P., et al. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.12.005 · Cited by 56
Mlejnek, P., Doležel, P., Kriegová, E., & Pastvova, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312635 · Cited by 58
Angiotensin II induces DNA damage via AT1 receptor and NADPH oxidase isoform Nox4
Fazeli, G., Stopper, H., Schinzel, R., Ni, C., Jo, H., & Schupp, N. (2012) · Mutagenesis · doi:10.1093/mutage/ges033 · Cited by 55
Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors
Cifuentes-Pagano, E., Meijles, D. N., & Pagano, P. J. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666151029112013 · Cited by 55
Moe, K. T., Khairunnisa, K., Yin, N. O., Chin-Dusting, J. P. F., Wong, P. E. H., & Wong, M. C. (2014) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-014-0345-0 · Cited by 54
Small-Molecule Inhibitors of NADPH Oxidase 4
Borbély, G., Szabadkai, I., Horváth, Z., Markó, P., Varga, Z. V., Breza, N., Baska, F., Vántus, T., Huszár, M., Geiszt, M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1004368 · Cited by 53
Schauen, M., Hornig‐Do, H., Schomberg, S., Herrmann, G., & Wiesner, R. J. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.11.016 · Cited by 54
Nox2 contributes to hyperinsulinemia-induced redox imbalance and impaired vascular function
Mahmoud, A. M., Ali, M. M., Miranda, E. R., Mey, J. T., Blackburn, B. K., Haus, J. M., & Phillips, S. A. (2017) · Redox Biology · doi:10.1016/j.redox.2017.06.001 · Cited by 52
Differential roles of NADPH oxidases in vascular physiology and pathophysiology
Griendling, K. K. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s317 · Cited by 52
Hirose, K., Shiomi, T., Hozumi, S., & Kikuchi, Y. (2014) · BMC Developmental Biology · doi:10.1186/s12861-014-0042-9 · Cited by 53
Targeting Reactive Oxygen Species in Hypertension
Delles, C., Miller, W. H., & Dominiczak, A. F. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.2008 · Cited by 51
Tsai, M.-H., & Jiang, M. J. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-67 · Cited by 51
Ishizawa, K., Izawa‐Ishizawa, Y., Ohnishi, S., Motobayashi, Y., Kawazoe, K., Hamano, S., Tsuchiya, K., Tomita, S., Minakuchi, K., & Tamaki, T. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08236fp · Cited by 50
The role of Nox-mediated oxidation in the regulation of cytoskeletal dynamics
Valdivia, A., Duran, C., & Martín, A. S. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666151029112624 · Cited by 51
Src Redox Regulation: There Is More Than Meets the Eye
Chiarugi, P. (2008) · Molecules and Cells · doi:10.1016/s1016-8478(23)14004-0 · Cited by 50
Li, D., Tong, J., Zeng, F., Guo, M., Li, Y., Wang, H., & Wang, P. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14506 · Cited by 47
DNA-based fluorescent probes of NOS2 activity in live brains
Veetil, A. T., Zou, J., Henderson, K. W., Jani, M. S., Shaik, S. M., Sisodia, S. S., Hale, M. E., & Krishnan, Y. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003034117 · Cited by 47
Targeted antioxidant therapies in hyperglycemia-mediated endothelial dysfunction
de Haan, J. B. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s182 · Cited by 47
Jiang, W., Zhong, S., Chen, Z., Qian, J., Huang, X., Zhang, H., Wen, L., Zhang, Y., & Yao, G. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121986 · Cited by 46
Inhibition of NADPH oxidase-1 preserves beta cell function
Weaver, J. R., Grzesik, W. J., & Taylor, D. (2014) · Diabetologia · doi:10.1007/s00125-014-3398-2 · Cited by 43
González, D. R., Treuer, A. V., Lamirault, G., Mayo, V., Cao, Y., Dulce, R. A., & Hare, J. M. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00890.2013 · Cited by 45
Qiu, Y., Tao, L., Lei, C., Wang, J., Yang, P., Li, Q., & Lei, B. (2015) · Scientific Reports · doi:10.1038/srep14362 · Cited by 43
Chang, K.-H., Park, J. M., Lee, C. H., Kim, B., Choi, K., Choi, S., Lee, K., & Lee, M. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.10.013 · Cited by 42
Connolly, M., Prieto‐Lloret, J., Becker, S., Ward, J. P. T., & Aaronson, P. I. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.253682 · Cited by 44
Scott, J. A., Xie, L., Li, H., Li, W., He, J. B., Sanders, P. N., Carter, A. B., Backs, J., Anderson, M. E., & Grumbach, I. M. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00978.2011 · Cited by 42
Vascular characterization of mice with endothelial expression of cytochrome P450 4F2
Cheng, J., Edin, M. L., Hoopes, S. L., Li, H., Bradbury, J. A., Graves, J. P., DeGraff, L. M., Lih, F. B., Garcia, V. G., Shaik, J. S., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-241927 · Cited by 41
Bridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitors
Cifuentes-Pagano, E., Saha, J., Csányi, G., Ghouleh, I. A., Sahoo, S., Rodriguez, A. I., Wipf, P., Pagano, P. J., & Skoda, E. M. (2013) · MedChemComm · doi:10.1039/c3md00061c · Cited by 39
The correlation of IRE1α oxidation with Nox4 activation in aging-associated vascular dysfunction
Lee, H., Kim, H., Hoang, T., Yang, S., Kim, H., & Chae, H. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101727 · Cited by 38
Redox signaling at invasive microdomains in cancer cells
Díaz, B., & Courtneidge, S. A. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.016 · Cited by 38
Zhang, L., Shao, J., Zhou, Y., Chen, H., Qi, H., Wang, Y., Chen, L., Zhu, Y., Zhang, M., Chen, L., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.010 · Cited by 37
Rajamohan, S. B., Raghuraman, G., Prabhakar, N. R., & Kumar, G. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4176 · Cited by 37
Chan, C. K. Y., Mak, J., Gao, Y., Man, R. Y. K., & Vanhoutte, P. M. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00258.2011 · Cited by 36
Bao, X.-M., Wu, C., & Lü, G. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.135 · Cited by 35
Li, L., Liu, S., Tan, J., Wei, L., Wu, D., Gao, S., Weng, Y., & Chen, J. (2022) · Journal of Tissue Engineering · doi:10.1177/20417314221088509 · Cited by 38
NADPH Oxidase Inhibition in Fibrotic Pathologies
Bernard, K. F., & Thannickal, V. J. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8032 · Cited by 34
Characterization of potent and selective iodonium-class inhibitors of NADPH oxidases
Lu, J., Risbood, P. A., Kane, C. T. J., Hossain, M. T., Anderson, L. D., Jr., Hill, K. D., Monks, A. P., Wu, Y., Antony, S., Juhasz, A. N., et al. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.07.007 · Cited by 32
NADPH Oxidases in Pain Processing
Kallenborn-Gerhardt, W., Schröder, K., & Schmidtko, A. (2022) · Antioxidants · doi:10.3390/antiox11061162 · Cited by 33
Synthetic and semi-synthetic antioxidants in medicine and food industry: a review
Tauchen, J., Huml, L., Jurášek, M., Regenstein, J. M., & Özoğul, F. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1599816 · Cited by 31
Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4
Xu, Q., Kulkarni, A. A., Sajith, A. M., Hussein, D., Brown, D., Güner, O. F., Motati, D. R., Watkins, E. B., Lassegue, B. P., Griendling, K. K., et al. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.12.023 · Cited by 30
Lu, W., Li, J. Y., Chen, R. J., Huang, L. T., Lee, T. Y., & Lin, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-55189-5 · Cited by 34
Pharmacological approaches to coronary microvascular dysfunction
Guarini, G., Huqi, A., Morrone, D., Capozza, P., Todiere, G., & Marzilli, M. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.008 · Cited by 31
Neuronal NADPH oxidase 2 regulates growth cone guidance downstream of slit2/robo2
Terzi, A., Roeder, H., Weaver, C. J., & Suter, D. M. (2020) · Developmental Neurobiology · doi:10.1002/dneu.22791 · Cited by 28
Bae, Y. S., Choi, S., Park, J. J., Joo, J. H., Cui, M., Cho, H., Lee, W., & Lee, S. H. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.06.056 · Cited by 28
Li, D., Cong, Z., Yang, C., & Zhu, X. D. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.134 · Cited by 27
Queisser, N., Schupp, N., Stopper, H., Schinzel, R., & Oteiza, P. I. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.08.028 · Cited by 24
Won, K., Lee, H. M., Lee, C., Lin, H. Y., Na, H., Lim, K. W., Roh, H. Y., Sim, S., Song, H., Choi, W. S., et al. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10250fp · Cited by 26
Reactive Oxygen Species, Cell growth, Cell Cycle Progression and Vascular Remodeling in Hypertension
Vokurková, M., Xu, S., & Touyz, R. M. (2006) · Future Cardiology · doi:10.2217/14796678.3.1.53 · Cited by 25
Chalcone suppresses tumor growth through NOX4-IRE1α sulfonation-RIDD-miR-23b axis
Kim, H., Lee, H.-Y., Riaz, T. A., Bhattarai, K. R., Chaudhary, M., Ahn, J. H., Jeong, J., Kim, H.-R., & Chae, H. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101853 · Cited by 25
Abubaker, A. A., Vara, D. S., Eggleston, I. M., Canobbio, I., & Pula, G. (2017) · Platelets · doi:10.1080/09537104.2017.1392497 · Cited by 24
Mendieta‐Serrano, M. A., Mendez-Cruz, F. J., Antunez‐Mojica, M., Schnabel, D., Álvarez, L., Cárdenas, L., Lomelı́, H., Ruiz-Santiesteban, J. A., & Vidal, E. S. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.416 · Cited by 23
Kim, J., & Moon, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212299 · Cited by 26
Arachidonic Acid and Nitroarachidonic: Effects on NADPH Oxidase Activity
González-Perilli, L., Prolo, C., & Álvarez, M. N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-11488-6_6 · Cited by 22
Mario, A. D., Peggion, C., Massimino, M. L., Norante, R. P., Zulian, A., Bertoli, A., & Sorgato, M. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184640 · Cited by 22
The NLRP3 Inflammasome in the Pathogenesis and Treatment of Alzheimer’s Disease
Golzari-Sorkheh, M., Brown, C. E., Weaver, D. F., & Reed, M. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210660 · Cited by 21
Targeting of Platelet-Derived Growth Factor Signaling in Pulmonary Arterial Hypertension
Berghausen, E. M., ten Freyhaus, H., & Rosenkranz, S. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-38664-0_16 · Cited by 21
Self-citationDual effect of advanced glycation end products in pancreatic islet apoptosis
Costal, F., de Oliveira, É. R. N. C., Raposo, A., Machado‐Lima, A., Peixoto, E. B. M. I., Roma, L. P., Santos, L. R. B., de Faria, J. B. L., Carpinelli, Â. R., Giannella‐Neto, D., et al. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2390 · Cited by 21
(2010) · SciVee · doi:10.4016/24063.01 · Cited by 21
Suppression of NADPH oxidase attenuates hypoxia-induced dysfunctions of endothelial progenitor cells
Liu, B., Ren, K., Peng, J.-J., Li, T., Luo, X., Fan, C., Yang, J., & Peng, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.161 · Cited by 20
Selective inhibition of NADPH oxidase reverses the over contraction of diabetic rat aorta
Rehman, A. U., Dugic, E., Benham, C. D., Lione, L. A., & Mackenzie, L. S. (2013) · Redox Biology · doi:10.1016/j.redox.2013.12.002 · Cited by 19
Kozina, A., Opresnik, S., Wong, M. S. K., Hallström, S., Graier, W. F., Malli, R., Schröder, K., Schmidt, K., & Frank, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113443 · Cited by 19
Differential Effects of Reactive Oxygen Species on IgG versus IgM Levels in TLR-Stimulated B Cells
Gilljam, K. M., Holm, K. L., Zahoor, M., Centonze, F. G., Farhan, H., & Blomhoff, H. K. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901131 · Cited by 19
Improved Agarose Gel Assay for Quantification of Growth Factor-Induced Cell Motility
Mousseau, Y., Leclers, D., Durand, K., Cook‐Moreau, J., Lia-Baldini, A.-S., Rigaud, M., & Sturtz, F. G. (2007) · BioTechniques · doi:10.2144/000112557 · Cited by 18
Avdonin, P. V., Rybakova, E. Y., Авдонин, П. П., Авдонин, П. П., Авдонин, П. П., Tsitrina, A. A., & Goncharov, N. V. (2019) · Cells · doi:10.3390/cells8020196 · Cited by 18
Characterisation of Nox4 Inhibitors from Edible Plants
Kofler, P., Pircher, H., von Grafenstein, S., Diener, T., Höll, M., Liedl, K. R., Siems, K., & Jansen‐Dürr, P. (2013) · Planta Medica · doi:10.1055/s-0032-1328129 · Cited by 18
Tarafdar, A., Wolska, N., Krisp, C., Schlüter, H., & Pula, G. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102287 · Cited by 18
Treuer, A. V., Faúndez, M., Ebensperger, R., Hovelmeyer, E., Vergara‐Jaque, A., Perera-Sardiña, Y., Gutiérrez, M., Fuentealba, R., & González, D. R. (2023) · Antioxidants · doi:10.3390/antiox12071441 · Cited by 18
Shaifta, Y., Snetkov, V. A., Prieto‐Lloret, J., Knock, G. A., Sv, S., Aaronson, P. I., & Ward, J. P. T. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv029 · Cited by 17
Li, Y., Zhao, W., Yu, X., Li, F., Liu, Z.-T., Li, L., & Xu, S. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8539026 · Cited by 17
Metabolic Regulation of the Ultradian Oscillator Hes1 by Reactive Oxygen Species
Ventre, S., Indrieri, A., Fracassi, C., Franco, B., Conte, I., Cardone, L., & di Bernardo, D. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.03.007 · Cited by 16
Li, L., Gao, P., rui, X., Wu, C., Zhu, D., Yan, J., & Lü, G. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05025.x · Cited by 16
Yang, J., Li, J., Wang, Q., Xing, Y., Tan, Z., & Kang, Q. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3612 · Cited by 16
Chopra, K., Folkmanaite, M., Stockdale, L., Shathish, V., Ishibashi, S., Bergin, R., Amich, J., & Amaya, E. (2023) · iScience · doi:10.1016/j.isci.2023.106147 · Cited by 17
Bao, X., & Zheng, H. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12435 · Cited by 15
Wagner, B., & Gorin, Y. C. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00371.2013 · Cited by 15
Molgat, A. S. D., Gagnon, A., & Sorisky, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.10.024 · Cited by 15
Noce, B., Marchese, S., Massari, M., Lambona, C., Reis, J., Fiorentino, F., Raucci, A., Fioravanti, R., Castelôa, M., Mormino, A., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02644 · Cited by 15
Mashmoushi, A. K., & Oates, J. C. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.02.031 · Cited by 13
Lee, H. M., Kim, H. J., Park, H., Won, K., Kim, J., Shin, H., Park, P., Kim, H., Lee, K.-Y., Park, S. H., et al. (2007) · Archives of Pharmacal Research · doi:10.1007/bf02977640 · Cited by 13
Metadata
- Authors
- TENFREYHAUS, H., HUNTGEBURTH, M., WINGLER, K., SCHNITKER, J., BAUMER, A., VANTLER, M., BEKHITE, M., WARTENBERG, M., SAUER, H., & ROSENKRANZ, S.
- Affiliations
- University of Cologne (DE)
- Vasopharm (Germany) (DE)
- Justus-Liebig-Universität Gießen (DE)
- Corresponding author
- ROSENKRANZ, S
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-07-15
- Volume
- 71
- Issue
- 2
- Pages
- 331-341
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2136386024
- Cited by
- 259
- References
- 46
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 4 · 2023: 8 · 2022: 7 · 2021: 13 · 2020: 15 · 2019: 15 · 2018: 13 · 2017: 14 · 2016: 9 · 2015: 19 · 2014: 22 · 2013: 24 · 2012: 22
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- VAS2870, platelet-derived growth factor, vascular smooth muscle cells, reactive oxygen species, cell proliferation, Src kinase, Akt, ERK, PDGF signaling, cell migration, DNA synthesis, cardiovascular disease, redox signaling, chemiluminescence, BrdU incorporation, immunofluorescence
- MeSH terms
- Becaplermin, Animals, Aorta, Thoracic, Benzoxazoles, Cell Survival, Cells, Cultured, Chemotaxis, DNA, Enzyme Inhibitors, Muscle, Smooth, Vascular, Platelet-Derived Growth Factor, Rats, Inbred WKY, Triazoles, Blotting, Western, Reactive Oxygen Species, src-Family Kinases, NADPH Oxidases, Proto-Oncogene Proteins c-sis, Myocytes, Smooth Muscle, Immunoprecipitation, Cell Proliferation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review